Table 2 Type and stage of cancer in the 418 oncogeriatric patients evaluated at the Geriatric Frailty Clinic
From: Impact of the comprehensive geriatric assessment on treatment decision in geriatric oncology
Characteristics | N (%) |
|---|---|
Type of cancers (solid cancers) | 339 (81.1) |
Digestive cancer | 124 (29.7) |
 Colorectal | 86 (69.3) |
 Stomach | 10 (8.1) |
 Pancreas cancer | 11 (8.9) |
 Other (esophageal, hepatic, duodenal, cholangiocarcinoma …) | 17 (13.7) |
Urologic cancer | 77 (18.4) |
 Bladder | 41 (53.2) |
 Kidney | 26 (33.8) |
 Prostate | 10 (13.0) |
Gynecologic cancer | 70 (16.8) |
 Breast | 52 (74.3) |
 Ovarian | 9 (12.9) |
 Other | 9 (12.9) |
Head and neck Cancer | 24 (5.7) |
Lung cancer | 18 (4.3) |
Skin cancer | 10 (2.4) |
Melanoma | 3 (0.30%) |
Non-melanoma | 7 (0.70%) |
Other | 16 (3.8) |
Cancer stage | |
 Local | 155 (37.1) |
 Loco-regional | 75 (17.9) |
 Metastasis | 109 (26.1) |
Hematological cancer | 79 (18.9) |
 Lymphoma | 23 (29.1) |
 Acute myelogenous leukemia | 1 (1.3) |
 Myelodysplastic syndrome | 8 (10.1) |
 Multiple myeloma | 13 (16.5) |
 Chronic lymphocytic leukemia | 34 (43.0) |